Entheon Biomedical (XCNQ:ENBI) Dividend Payout Ratio : 0.00 (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Dividend Payout Ratio?

Entheon Biomedical's dividend payout ratio for the months ended in Feb. 2024 was 0.00.

The historical rank and industry rank for Entheon Biomedical's Dividend Payout Ratio or its related term are showing as below:

XCNQ:ENBI's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.455
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-14), the Dividend Yield % of Entheon Biomedical is 0.00%.

Entheon Biomedical's Dividends per Share for the months ended in Feb. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Entheon Biomedical Dividend Payout Ratio Historical Data

The historical data trend for Entheon Biomedical's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Dividend Payout Ratio Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Dividend Payout Ratio

Get a 7-Day Free Trial

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Entheon Biomedical's Dividend Payout Ratio

For the Biotechnology subindustry, Entheon Biomedical's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Dividend Payout Ratio falls into.

Entheon Biomedical Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Entheon Biomedical's Dividend Payout Ratio for the fiscal year that ended in Nov. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Nov. 2023 )	/	EPS without NRI (A: Nov. 2023 )
	=	0	/	-0.051
	=	N/A

Entheon Biomedical's Dividend Payout Ratio for the quarter that ended in Feb. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Feb. 2024 )	/	EPS without NRI (Q: Feb. 2024 )
	=	0	/	-0.01
	=	N/A

Entheon Biomedical (XCNQ:ENBI) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Entheon Biomedical Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines